F-group (family)
7529.1.1.4 PARG_cat_C
Ligands and drugs
77
Member domains
52
with ligand contacts (≤ 4 Å)
67.5% of members
47
with DrugDomain annotations
61.0% of members
25
with a DrugBank compound
32.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7529.1.1.4 belongs to X-group 7529 Macro domain-like, which binds 9.2 ligand superclasses per 20 proteins, broader than 83% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02059 | AR6 | Adenosine-5-Diphosphoribose | 5 |
| DB02184 | DTV | D-1,4-dithiothreitol | 3 |
| DB03766 | PPI | Propanoic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| A1R | 5'-O-[(S)-{[(S)-{[(2R,3R,4S)-3,4-DIHYDROXYPYRROLIDIN-2-YL]METHOXY}(HYDROXY)PHOSPHORYL]OXY}(HYDROXY)PHOSPHORYL]ADENOSINE | 7 |
| AR6 | [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE | 6 |
| DTV | (2S,3S)-1,4-DIMERCAPTOBUTANE-2,3-DIOL | 3 |
| IOD | IODIDE ION | 3 |
| LQX | 1-[(2,5-dimethylpyrazol-3-yl)methyl]-N-(1-methylcyclopropyl)-3-[(2-methyl-1,3-thiazol-5-yl)methyl]-2,4-bis(oxidanylidene)quinazoline-6-sulfonamide | 3 |
| APR | ADENOSINE-5-DIPHOSPHORIBOSE | 2 |
| M0M | (8S)-1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]sulfanyl}-6-sulfanylidene-1,3,6,7,8,9-hexahydro-2H-purin-2-one | 2 |
| M0P | 1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]sulfanyl}-3,7-dihydro-1H-purine-2,6-dione | 2 |
| 0RR | 3-{(5Z)-5-[5-chloro-1-(2,6-dichlorobenzyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}propanoic acid | 1 |
| 6WJ | 1-(cyclopropylmethyl)-6-[[(1-methylcyclopropyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-3-[(2-methyl-1,3-thiazol-5-yl)methyl]quinazoline-2,4-dione | 1 |
| 70J | 3-methyl-6-[[(1-methylcyclopropyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-1-(phenylmethyl)quinazoline-2,4-dione | 1 |
| 73L | 1-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-6-[[(1-methylcyclopropyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-3-[(1-methylpyrazol-4-yl)methyl]quinazoline-2,4-dione | 1 |
| 7JB | ~{N}-~{tert}-butyl-9,10-bis(oxidanylidene)anthracene-2-sulfonamide | 1 |
| 7JC | 1-methyl-~{N}-(1-methylcyclopropyl)-3-[(2-methyl-1,3-thiazol-5-yl)methyl]-2,4-bis(oxidanylidene)quinazoline-6-sulfonamide | 1 |
| A3R | Adenosine Diphosphate (Hydroxymethyl)pyrrolidine monoalcohol | 1 |
| A8P | 8-n-octylamino-adenosine diphosphate hydroxypyrrolidinediol | 1 |
| M0S | 1,3-dimethyl-8-{[2-(pyrrolidin-1-yl)ethyl]sulfanyl}-6-sulfanylidene-1,3,6,9-tetrahydro-2H-purin-2-one | 1 |
| M0V | 7-[(2S)-2-hydroxy-3-(morpholin-4-yl)propyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | 1 |
| M1D | 4-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)butanoic acid | 1 |
| PPI | PROPANOIC ACID | 1 |